发明名称 |
Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE |
摘要 |
The present disclosure provides a method for recombinant production of human sRAGE in mammalian cells, as well as a human sRAGE having a mammalian post-translational modification and compositions thereof. The present disclosure also provides a method of treating a vascular disease, injury, or inflammation in a mammal by administering to a mammal with a vascular disease, injury, or inflammation a composition comprising human sRAGE having a mammalian post-translational modification, thereby treating the vascular disease, injury, or inflammation in the mammal. |
申请公布号 |
US9175062(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US201314368374 |
申请日期 |
2013.01.03 |
申请人 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
发明人 |
Lin Li;Park Sungha;Wei Wen;Xiao Rui-Ping;Talan Mark I.;Lakatta Edward G. |
分类号 |
C07K14/705;A61K38/17 |
主分类号 |
C07K14/705 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. A method of treating a vascular disease, vascular injury or vascular inflammation in a mammal, comprising administering to the mammal an isolated human soluble receptor for advanced glycation end products (sRAGE) polypeptide comprising a mammalian post-translation modification, wherein the amino acid sequence of the sRAGE polypeptide is at least 95% identical to SEQ ID NO: 4 and the mammalian post-translation modification comprises mammalian N-glycosylation, thereby treating the vascular disease, vascular injury, or vascular inflammation in the mammal. |
地址 |
Washington DC US |